Molecular-genetic imaging: Current and future perspectives

Journal of Clinical Investigation

Volumn 111, Issue 11, 2003, Pages 1620-1629

  Blasberg, Ronald G ^a   Tjuvajev, Juri Gelovani ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER ASSISTED TOMOGRAPHY; GENE THERAPY; IMAGE ANALYSIS; IMAGING SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; ULTRASOUND; ANIMAL; BIOLOGICAL MODEL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC IMAGING; GENE EXPRESSION REGULATION; GENETIC PROCEDURES; HUMAN; METABOLISM; METHODOLOGY; NEOPLASM; PATHOLOGY; REPORTER GENE; TIME;

IMATINIB; PIPERAZINE DERIVATIVE; PROTEIN P53; PYRIMIDINE DERIVATIVE;

ANIMALS; DIAGNOSTIC IMAGING; GENE EXPRESSION REGULATION; GENES, REPORTER; GENETIC TECHNIQUES; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; PIPERAZINES; PYRIMIDINES; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0038142321     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI18855     Document Type: Review

References (58)

1. Blasberg, R., and Gelovani Tjuvajev, J. 2002. Molecular imaging: a nuclear based perspective. Molecular Imaging. 1:160-180.
2. Weissleder, R., Reimer, P., Lee, A.S., Wittenberg, J., and Brady, T.J. 1990. MR receptor imaging: ultra small iron oxide particles targeted to asialo-glycoprotein receptors. Am. J. Roentgenol. 6:1161-1167.
3. Weissleder, R., et al. 1991. Polyclonal human immunoglobulin G labeled with polymeric iron oxide: antibody MR imaging. Radiology. 1:245-249.
4. Kayyem, J.F., Kumar, R.M., Fraser, S.E., and Meade, T.J. 1995. Receptor-targeted co-transport of DNA and magnetic resonance contrast agents. Chem. Biol. 9:615-620.
5. Weissleder, R., et al. 1997. MR imaging and scintigraphy of gene expression through melanin induction. Radiology. 2:425-429.
6. Louie, A.Y., et al. 2000. In vivo visualization of gene expression using magnetic resonance imaging. Nat. Biotechnol. 3:321-325.
7. Tjuvajev, J.G., et al. 1995. Imaging the expression of transfected genes in vivo. Cancer Res. 55:6126-6132.
8. Tjuvajev, J.G., et al. 1996. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: a potential method for monitoring clinical gene therapy. Cancer Res. 56:4087-4095.
9. Tjuvajev, J.G., et al. 1998. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res. 58:4333-4341.
10. Gambhir, S.S., et al. 1998. Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir. J. Nucl. Med. 11:2003-2011.
11. Gambhir, S.S., et al. 1999. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc. Natl. Acad. Sci. U. S. A. 5:2333-2338.
12. Contag, C.H., et al. 1997. Visualizing gene expression in living mammals using a bioluminescent reporter. Photochem. Photobiol. 66:523-531.
13. Contag, P.R., Olomu, I.N., Stevenson, D.K., and Contag, C.H. 1998. Bioluminescent indicators in living mammals. Nat. Med. 4:245-247.
14. Rehemtulla, A., et al. 2000. Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging. Neoplasia. 6:491-495.
15. 14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 5:897-916.
16. Reivich, M., et al. 1977. Measurement of local cerebral glucose metabolism in man with 18F-2-fluoro-2-deoxy-d-glucose. Acta Neurol. Scand. Suppl. 64:190-191.
17. Miyagawa, T., et al. 1998. "Facilitated" amino acid transport is up-regulated in brain tumors. J. Cereb. Blood Flow Metab. 18:500-509.
18. Haberkorn, U. 2001. Gene therapy with sodium/iodide symporter in hepatocarcinoma. Exp. Clin. Endocrinol. Diabetes. 1:60-62.
19. Dewanjee, M.K., et al. 1994. Noninvasive imaging of c-myc oncogene messenger RNA with indium-111-antisense probes in a mammary tumor-bearing mouse model. J. Nucl. Med. 6:1054-1063.
20. Tavitian, B., et al. 1998. In vivo imaging of oligonucleotides with positron emission tomography. Nat. Med. 4:467-471.
21. Tjuvajev, J.G., et al. 1999. A general approach to the non-invasive imaging of transgenes using cis-linked herpes simplex virus thymidine kinase. Neoplasia. 4:315-320.
22. Yu, Y., et al. 2000. Quantification of target gene expression by imaging reporter gene expression in living animals. Nat. Med. 8:933-937.
23. Sweeney, T.J., et al. 1999. Visualizing the kinetics of tumor-cell clearance in living animals. Proc. Natl. Acad. Sci. U. S. A. 21:12044-12049.
24. Mayerhofer, R., Araki, K., and Szalay, A.A. 1995. Monitoring of spatial expression of firefly luciferase in transformed zebrafish. J. Biolumin. Chemilumin. 5:271-275.
25. Doubrovin, M., et al. 2001. Imaging transcriptional regulation of p53-dependent genes with positron emission tomography in vivo. Proc. Natl. Acad. Sci. U. S. A. 98:9300-9305.
26. Ponomarev, V., et al. 2001. Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo. Neoplasia. 3:480-488.
27. Iyer, M., et al. 2001. Two-step transcriptional amplification as a method for imaging reporter gene expression using weak promoters. Proc. Natl. Acad. Sci. U. S. A. 25:14595-14600.
28. Gambhir, S.S., et al. 2000. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. Proc. Natl. Acad. Sci. U. S. A. 6:2785-2790.
29. Tjuvajev, J.G., et al. 2002. Comparison of radiolabeled nucleoside probes (FIAU, FHBG and FHPG) for PET imaging of HSV1-tk gene expression. J. Nucl. Med. 8:1072-1083.
30. MacLaren, D.C., et al. 1999. Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther. 5:785-791.
31. Rogers, B.E., Zinn, K.R., and Buchsbaum, D.J. 2000. Gene transfer strategies for improving radiolabeled peptide imaging and therapy. Q. J. Nucl. Med. 3:208-223.
32. 18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans. Journal of Cerebral Metabolism and Blood Flow. 9:830-839.
33. Hemminki, A., et al. 2001. An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression. Mol. Ther. 3:223-231.
34. Moon, D.H., et al. 2001. Correlation between 99mTc-pertechnetate uptakes and expressions of human sodium iodide symporter gene in breast tumor tissues. Nucl. Med. Biol. 7:829-834.
35. Jacobs, A., et al. 2001. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet. 9283:727-729.
36. Demetri, G.D., et al. 2002. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N. Engl. J. Med. 347:472-480.
37. Van den Abbeele, A.D., for the GIST Collaborative PET Study Goup (Dana-Farber Cancer Institute, Boston, Massachusetts, USA, OSU, Portlat, Oregon, Helsinki University Central Hopital, Turku University Central Hospital, Finland, Novartis Oncology). 2001. F18-FDG-PET provides early evidence of biological response to STI571 patients with malignant gastrontestinal stromal tumors (GIST). Proc. Am. Soc. Clin. Oncol. 20:362a.
38. Frauwirth, K.A., et al. 2002. The CD28 signaling pathway regulates glucose metabolism. Immunity. 6:769-777.
39. Peng, T., Golub, T.R., and Sabatini, D.M. 2002. The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation. Mol. Cell. Biol. 15:5575-5584.
40. Jolly, D. 1994. Viral vector systems for gene delivery. Cancer Gene Ther. 1:51-64.
41. Qiao, J., et al. 2002. Tumor-specific transcriptional targeting of suicide gene therapy. Gene Ther. 9:168-175.
42. 124I]FIAU and PET. Molecular Imaging. 1:36-42.
43. Tjuvajev, J.G., et al. 1999. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res. 59:5186-5193.
44. Bennett, J.J., et al. 2001. Positron emission tomography imaging for herpes virus infection: implications for oncolytic viral treatments of cancer. Nat. Med. 7:859-863.
45. Jacobs, A., et al. 2001. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Cancer Res. 61:2983-2995.
46. Merritt, J.A., Roth, J.A., and Logothetis, C.J. 2001. Clinical evaluation of adenoviral-mediated p53 gene transfer: review of INGN 201 studies. Semin. Oncol. 16(Suppl.):S105-S114.
47. Ercikan-Abali, E.A., et al. 1993. Translational regulation of the synthesis of dihydrofolate reductase. Adv. Exp. Med. Biol. 338:537-540.
48. Mayer-Kuckuk, P., et al. 2002. Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase: a method to modulate gene expression. Proc. Natl. Acad. Sci. U. S. A. 6:3400-3405.
49. Ray, P., et al. 2002. Non-invasive quantitative imaging of protein-protein interactions in living subjects. Proc. Natl. Acad. Sci. U. S. A. 5:3105-3110.
50. Luker, G.D., et al. 2002. Noninvasive imaging of protein-protein interactions in living animals. Proc. Natl. Acad. Sci. U. S. A. 10:6961-6966.
51. Rosenberg, S.A., et al. 1990. Gene transfer into humans: immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N. Engl. J. Med. 323:570-578.
52. Rooney, C.M., et al. 1995. Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation. Lancet. 345:9-13.
53. Verzeletti, S., et al. 1998. Herpes simplex virus thymidine kinase gene transfer for controlled graft-versus-host disease and graft-versus-leukemia: clinical follow-up and improved new vectors. Hum. Gene Ther. 9:2243-2251.
54. Bonini, C., et al. 1997. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia. Science. 276:1719-1724.
55. Heslop, H., et al. 2000. Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease. Hum. Gene Ther. 11:1465-1475.
56. Adonai, N., et al. 2002. Ex vivo cell labeling with 64Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) for imaging cell trafficking in mice with positron-emission tomography. Proc. Natl. Acad. Sci. U. S. A. 99:3030-3035.
57. Koehne, G., et al. 2003. Serial in vivo imaging of the targeted migration of human HSV-TK-transduced antigen-specific lymphocytes. Nat. Biotechnol. 21:405-513.
58. Jacobs, A., et al. 2001. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet. 358:727-729.